HRT Financial’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,286
| Closed | -$26K | – | 2200 |
|
|
2025
Q1 | $26K | Buy |
+17,286
| New | +$26K | ﹤0.01% | 2049 |
|
|
2024
Q3 | – | Sell |
-81,005
| Closed | -$89K | – | 2155 |
|
|
2024
Q2 | $89K | Buy |
+81,005
| New | +$89K | ﹤0.01% | 1602 |
|
|
2023
Q1 | – | Sell |
-45,535
| Closed | -$717K | – | 2234 |
|
|
2022
Q4 | $717K | Buy |
+45,535
| New | +$717K | 0.01% | 1114 |
|
|
2021
Q2 | – | Sell |
-152,119
| Closed | -$3.83M | – | 2664 |
|
|
2021
Q1 | $3.83M | Buy |
+152,119
| New | +$3.83M | 0.04% | 291 |
|
|
2020
Q1 | – | Sell |
-49,323
| Closed | -$93K | – | 591 |
|
|
2019
Q4 | $93K | Buy |
+49,323
| New | +$93K | ﹤0.01% | 986 |
|